UPNEEQ

Upneeq® (oxymetazoline hydrochloride ophthalmic solution 0.1%) is a prescription eye drop used to treat acquired blepharoptosis, a condition characterized by low-lying upper eyelids in adults.

How It Works

Upneeq stimulates Müller’s muscle, a muscle in the eyelid responsible for lifting, through alpha-adrenergic receptor activation. Most patients see results within 15 minutes, with effects lasting up to 6–8 hours. Each dose comes in a single-use vial.

Who It’s For

• Adults with mild-to-moderate acquired ptosis

• Individuals seeking a non-surgical, temporary eyelid lift

• Patients who experience eyelid drooping due to aging, fatigue, or post-Botox effects

Who Should Avoid Upneeq

• Individuals with untreated narrow-angle glaucoma

• Patients with uncontrolled hypertension or significant heart conditions

• Those taking monoamine oxidase inhibitors (MAOIs), beta-blockers, or certain blood pressure medications

• People with neurological disorders like Horner’s syndrome or myasthenia gravis

Potential Side Effects

While generally well tolerated, possible side effects may include:

• Eye redness, dryness, or irritation

• Blurred vision

• Headache or dizziness

• Conjunctivitis or mild eye pain

Important Note

Patients should discontinue use and consult a healthcare provider if they experience worsening symptoms, eye pain, visual changes, or signs of increased eye pressure.

Summary

Upneeq is a fast-acting, non-invasive treatment option for acquired ptosis. It is ideal for individuals looking for a temporary lift to their upper eyelids without surgery. A medical consultation is required to ensure eligibility and safety.

Cost

$250 for a box of 45

$165 for a box of 30